SCHEMBL3539481

SCHEMBL3539481

CN1CCN(c2ccc(NC(=O)C(F)(F)F)c(N3CCC(F)CC3)c2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 10/20 0.54
NTRK1 P04629 1/20 0.50
KIT P10721 1/20 0.50
AXL P30530 1/20 0.50
FLT3 P36888 1/20 0.50
KDM4E B2RXH2 1/20 0.48
GAA P10253 1/20 0.48
MAPT P10636 1/20 0.48
MAPK1 P28482 1/20 0.48
HTT P42858 1/20 0.48
RECQL P46063 1/20 0.48
PTK2B Q14289 1/20 0.48
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
HDAC3 O15379 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
WDR5 P61964 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
SRPK1 Q96SB4 1/20 0.41
ABL1 P00519 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3545923 0.88 CSF1R (0.61) CSF1RNTRK1KITAXLFLT3
Trifluoroacetic Acid SCHEMBL3539482 0.81 MAPT (0.64) CSF1RNTRK1KITAXLFLT3
SCHEMBL3543649 0.81 CSF1R (0.66) CSF1RNTRK1KITAXLFLT3
SCHEMBL3539636 0.80 CSF1R (0.61) CSF1RNTRK1KITAXLFLT3
SCHEMBL13405757 0.79 CSF1R (0.86) CSF1RKIT
Trifluoroacetic Acid SCHEMBL3539479 0.76 KDM4E (0.47) CSF1RKDM4EGAAMAPTMAPK1
SCHEMBL3545551 0.76 MAPT (0.82) KDM4EGAAMAPTMAPK1HTT
SCHEMBL3962010 0.75 KDM4E (0.54) CSF1RNTRK1KITAXLFLT3
SCHEMBL20598677 0.73 CSF1R (0.56) CSF1RNTRK1KITAXLFLT3
SCHEMBL20598030 0.71 CHEK1 (0.58) CSF1RNTRK1KITAXLFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1807407-B1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2009-07-29 EP claimed
EP-1807407-A1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-18 EP claimed
US-20060100201-A1 Inhibitors of c-fms kinase JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-11 US claimed
WO-2006047504-A1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-04 WO claimed
US-7705042-B2 Class of arylamide compounds useful as inhibitors of c-fms kinase JANSSEN PHARMACEUTICA NV (BE) 2010-04-27 US disclosed
EP-1807407-B1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2009-07-29 EP disclosed
EP-1807407-A1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-18 EP disclosed
US-20060100201-A1 Inhibitors of c-fms kinase JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-11 US disclosed
WO-2006047504-A1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100201-A1 Inhibitors of c-fms kinase MUSK, FLT3, FES CSF1R 34/4885NTRK1 143/4885KIT 155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.